Elsevier

Brain Research

Volume 677, Issue 1, 17 April 1995, Pages 138-144
Brain Research

Effect of NMDA receptor antagonists on prostaglandin E2-induced hyperalgesia in conscious mice

https://doi.org/10.1016/0006-8993(95)00133-BGet rights and content

Abstract

Intrathecal (i.t.) injection of prostaglandin E2 (PGE2) to conscious mice produced a hyperalgesic action over a wide range of dosages with two apparent peaks at 100 pg and 10 ng per mouse, which may be mediated through EP3 and EP2 subtypes of the PGE receptor. In the present study, the effects of NMDA receptor antagonists on hyperalgesia induced by PGE2 were evaluated by the hot plate test at 30 min after i.t. injection. Hyperalgesia induced by a higher dose of PGE2 (10 ng/mouse) was relieved byd-AP5 (a competitive antagonist), 7-Cl-KynA (a glycine site antagonist), and ketamine and MK801 (non-competitive channel blockers). Intrathecal injection of butaprost (10 ng/mouse), an EP2 agonist, induced hyperalgesia, and this hyperalgesia was blocked byd-AP5, 7-Cl-KynA, ketamine, and MK801, similar to that induced by 10 ng of PGE2. On the other hand, hyperalgesia induced by a lower dose of PGE2 (100 pg/mouse) was blocked byd-AP5 and 7-Cl-KynA, but not by ketamine and MK801. Intrathecal injection of sulprostone (100 pg/mouse), an EP1 and EP3 agonist, induced hyperalgesia, and this hyperalgesia was blocked byd-AP5 and 7-Cl-KynA, but not by ketamine and MK801, similar to that induced by 100 pg of PGE2. These results first demonstrate that the NMDA receptor is involved in the PGE2-induced hyperalgesia and suggest that the hyperalgesic action by lower and higher doses of PGE2 may be mediated through EP3 and EP2 subtypes, respectively.

References (41)

Cited by (38)

  • TRP-channels as key integrators of lipid pathways in nociceptive neurons

    2014, Progress in Lipid Research
    Citation Excerpt :

    Deorphanizing of GPCRs is a promising approach for the identification of novel or formerly unrelated lipid receptors in sensory neurons and may open novel therapeutic perspectives for the development of analgesics. Even though EP and IP-receptor signaling can modulate postsynaptic AMPA- and NMDA-receptor activity [136–138] and endocannabinnoid signaling can modulate Cav-activity [139,140], TRP channels represent the biggest family of ion channels with known lipid GRPC dependent modulation. However, the role of lipid GPCRs in modulating other ligand- or voltage-gated ion channels, which are important for nociceptive processing, such as ASIC, HCN, ANO1, Piezos, TREK1, Nav and Kv, still remains to be elucidated.

  • Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr<sup>6</sup>] γ2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice

    2009, Brain Research
    Citation Excerpt :

    Intrathecal NMDA produced a significant decrease in the response latencies to noxious thermal stimulation (Aanonsen et al., 1990; Kolhekar et al., 1993; Meller et al., 1992a,b, 1996; Raigorodsky and Urca, 1987). Furthermore NMDA receptor may be involved in the hyperalgesic effects induced by some substances intrathecally, including histamine (Sakurada et al., 2002a), prostaglandin E2 (Nishihara et al., 1995), and α, β-methylene ATP (Tsuda et al., 1999). Our results showed that MrgC agonist [Tyr6]- γ2-MSH(6-12) administered intrathecally induced hyperalgesic effect in a dose-dependent manner.

View all citing articles on Scopus
View full text